- Dr. Paul Offit, a member of the FDA’s Vaccine Advisory Committee, said he’s not fully sold on the benefits of a third shot outweighing the harm
- A newly developed dose, called a bivalent vaccine, is a cocktail of the original coronavirus strain combined with parts of the omicron BA.4 and BA.5 subvariants
- The CDC has reported that the old vaccine has side-effects like myocarditis, an – inflammation of the heart muscle and pericarditis, an inflammation of the heart’s outer lining
- So far, the only tests on the new shots have been done on lab mice
https://www.dailymail.co.uk/news/article-11247181/FDA-vaccine-adviser-says-healthy-young-people-SHOULDNT-COVID-booster.html
Like this:
Like Loading...
Published by markskidmore
Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.
View more posts